July 19 (Reuters) - Kalytera Therapeutics Inc KALY.V :
* KALYTERA TO ENTER MEDICAL CANNABIS MARKET WITH FOCUS ON TREATMENT OF PSORIASIS AND MENSTRUAL CRAMPS
* KALYTERA THERAPEUTICS INC - ENTERED INTO AN AGREEMENT WITH BEETLEBUNG PHARMA
* KALYTERA THERAPEUTICS - DEAL FOR OPTION TO BUY RIGHTS TO MEDICAL CANNABIS PRODUCTS IN DEVELOPMENT BY BPL
* KALYTERA THERAPEUTICS - WILL HAVE OPTION TO LICENSE FROM BPL CERTAIN PROPRIETARY MEDICAL CANNABIS FORMULATIONS